Mycobacteria Registry Study: Prospective Observational Study in Austria
NCT06522347 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2024-07-26
Summary
The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is:
What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria?
Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.
Conditions
- Non-Tuberculous Mycobacterial Pneumonia
- Tuberculosis
Sponsors & Collaborators
-
Sigmund Freud PrivatUniversitat
collaborator OTHER -
Ludwig Boltzmann Institute for Lung Health
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-01
- Primary Completion
- 2053-12-31
- Completion
- 2053-12-31
Countries
- Austria
Study Locations
More Related Trials
-
TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
NCT03251196 ·Status: UNKNOWN
-
Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission
NCT02355223 ·Status: UNKNOWN ·Phase: NA
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines
NCT05592223 ·Status: COMPLETED ·Phase: PHASE1
-
Rifampicin at High Dose for Difficult-to-Treat Tuberculosis
NCT04768231 ·Status: UNKNOWN ·Phase: PHASE2
-
A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis
NCT05575518 ·Status: RECRUITING ·Phase: PHASE3
-
Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis
NCT03160638 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients
NCT03409315 ·Status: UNKNOWN
-
Epidemiology of MDR-TB in Peru
NCT00676754 ·Status: UNKNOWN
-
Effectiveness of Active Case Finding of Household Contacts in a Routine Tuberculosis (TB) Control Program
NCT02174380 ·Status: UNKNOWN ·Phase: NA
-
A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis
NCT06875336 ·Status: RECRUITING
-
Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis
NCT04700579 ·Status: RECRUITING
-
Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial
NCT05017324 ·Status: UNKNOWN ·Phase: NA
-
A Pragmatic Randomised Study to Optimise Screening, Prevention and Care for Tuberculosis in Malawi
NCT03519425 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis
NCT00402454 ·Status: COMPLETED ·Phase: PHASE4
-
Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study
NCT05653193 ·Status: RECRUITING ·Phase: PHASE2
-
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)
NCT07163143 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Comparing Expectorated and Induced Sputum and Pharyngeal Swabs for Cultures, AFB Smears, and Cytokines in Pulmonary Nontuberculous Mycobacterial Infection
NCT01150721 ·Status: COMPLETED
-
Evaluation of Tuberculosis Treatment Outcomes
NCT06942975 ·Status: COMPLETED
-
A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy
NCT00402610 ·Status: COMPLETED ·Phase: PHASE4
-
Expression of Tuberculosis in the Lung
NCT00201253 ·Status: COMPLETED
-
Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design
NCT01785186 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Registry For Patients With Non-Tuberculous Mycobacterial (NTM) Pulmonary Disease in Korea.
NCT03934034 ·Status: NOT_YET_RECRUITING
-
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
NCT06114628 ·Status: RECRUITING ·Phase: PHASE2
-
Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens
NCT05871489 ·Status: ACTIVE_NOT_RECRUITING